Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws

Oral Diseases

Volumn 15, Issue 1, 2009, Pages 88-92

  Treister, N ^a,b   Sheehy, N ^c   Bae, E H ^d   Friedland, B ^b   Lerman, M ^a,b   Woo, S ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Bisphosphonates; Osteonecrosis of the jaws; Panoramic radiography

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ARTICLE; BONE NECROSIS; BREAST CANCER; CLINICAL FEATURE; DISEASE SEVERITY; GAUCHER DISEASE; HUMAN; JAW OSTEONECROSIS; LUNG CANCER; MULTIPLE MYELOMA; OSTEOPOROSIS; PANORAMIC RADIOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DENTAL ARCH; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MALE; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOLYSIS; OSTEONECROSIS; OSTEOSCLEROSIS; PROSTATIC NEOPLASMS; RADIOGRAPHY, DENTAL, DIGITAL; RADIOGRAPHY, PANORAMIC; RETROSPECTIVE STUDIES; TOOTH SOCKET;

EID: 57549093828     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2008.01494.x     Document Type: Article

References (26)

1. American Association of Oral and Maxillofacial Surgeons (2007). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65 : 369 376.
2. Bamias A, Kastritis E, Bamia C et al (2005). Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 : 8580 8587.
3. Bedogni A, Saia G, Ragazzo M et al (2007). Bisphosphonate-associated osteonecrosis can hide jaw metastases. Bone 41 (6 942 945.
4. Bedogni A, Blandamura S, Lokmic Z et al (2008). Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105 : 358 364.
5. Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M (2007). Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 : 249 258.
6. Blackwelder WC (1982). 'Proving the null hypothesis' in clinical trials. Control Clin Trials 3 : 345 353.
7. Brenner DJ, Hall EJ (2007). Computed tomography - an increasing source of radiation exposure. N Engl J Med 357 : 2277 2284.
8. Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R (2006). Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35 : 236 243.
9. Clezardin P, Ebetino FH, Fournier PG (2005). Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity. Cancer Res 65 : 4971 4974.
10. Durie BG, Katz M, Crowley J (2005). Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353 (1 99 102. discussion.
11. Fullmer JM, Scarfe WC, Kushner GM, Alpert B, Farman AG (2007). Cone beam computed tomographic findings in refractory chronic suppurative osteomyelitis of the mandible. Br J Oral Maxillofac Surg 45 : 364 371.
12. Groetz KA, Al-Nawas B (2006). Persisting alveolar sockets-a radiologic symptom of BP-ONJ? J Oral Maxillofac Surg 64 (10 1571 1572.
13. Khosla S, Burr D, Cauley J et al (2007). Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the american society for bone and mineral research. J Bone Miner Res 22 (10 1479 1491.
14. Ludlow JB, Davies-Ludlow LE, Brooks SL, Howerton WB (2006). Dosimetry of 3 CBCT devices for oral and maxillofacial radiology: CB Mercuray, NewTom 3G and i-CAT. Dentomaxillofac Radiol 35 : 219 226.
15. Marx RE (2003). Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 : 1115 1117.
16. Marx RE, Sawatari Y, Fortin M, Broumand V (2005). Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 : 1567 1575.
17. Merck (2007). http://www.merck.com/newsroom/press_releases/product/ fosamax_statement.html.
18. Milillo P, Garribba AP, Favia G, Ettorre GC (2007). Jaw osteonecrosis in patients treated with bisphosphonates: MDCT evaluation. Radiol Med Torino 112 : 603 611.
19. Murad OM, Arora S, Farag AF, Guber HA (2007). Bisphosphonates and osteonecrosis of the jaw: a retrospective study. Endocr Pract 13 (3 232 238.
20. Ott SM (2005). Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90 : 1897 1899.
21. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004). Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 : 527 534.
22. Scarfe WC, Farman AG, Sukovic P (2006). Clinical applications of cone-beam computed tomography in dental practice. J Can Dent Assoc 72 : 75 80.
23. Serman NJ (1989). Pitfalls of panoramic radiology in implant surgery. Ann Dent 48 : 13 16.
24. Tsiklakis K, Donta C, Gavala S, Karayianni K, Kamenopoulou V, Hourdakis CJ (2005). Dose reduction in maxillofacial imaging using low dose cone beam CT. Eur J Radiol 56 : 413 417.
25. Woo SB, Hellstein JW, Kalmar JR (2006). Narrative (corrected) review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 : 753 761.
26. Zervas K, Verrou E, Teleioudis Z et al (2006). Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients. Br J Haematol 134 : 620 623.